Skip to main navigation Skip to search Skip to main content

Methylene violet 3RAX-conjugated porphyrin for photodynamic therapy: Synthesis, DNA photocleavage, and cell study

  • Si Yao
  • , Yunman Zheng
  • , Lijun Jiang
  • , Chen Xie
  • , Fengshou Wu*
  • , Chi Huang
  • , Xiong Zhang
  • , Ka Leung Wong
  • , Zaoying Li
  • , Kai Wang
  • *Corresponding author for this work

Research output: Journal article › peer-review

28 Citations (Scopus)

Abstract

A methylene violet 3RAX-conjugated porphyrin has been designed and synthesized as a potential photosensitizer in photodynamic therapy because of its high DNA binding constant and the efficacy in inhibiting cancer cells with subcellular localization.

Original languageEnglish
Pages (from-to)4472-4477
Number of pages6
JournalRSC Advances
Volume8
Issue number8
DOIs
Publication statusPublished - 24 Jan 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Methylene violet 3RAX-conjugated porphyrin for photodynamic therapy: Synthesis, DNA photocleavage, and cell study'. Together they form a unique fingerprint.

Cite this